Podcast appearances and mentions of leigh purvis

00:00 Show open/ Leigh Purvis, Prescription Drug Policy Principal at AARP on Medicare prescription drug caps. 6:33 Marc Selvitelli, CEO of NAIOP (Commercial Real Estate Trade Association) on the usage, downsizing, and repurposing of office space in Columbus. 14:38 Face the State: Facts about the presidential inauguration, Ohio Republican party Vice Chair And Franklin County Republican party Chair Meredith Freedhoff on attending the inauguration. Ohio Sen. Bernie Moreno (R) on the inauguration. Ohio Governor Mike DeWine on possible ambassadorship. 26:05 Face the State: Central Ohio's new and historic economic development project. Ohio school funding cuts. MLK day history and information.

Scott Ladner, chief investment officer at Horizon Investments, says that the stock market will need earnings growth to generate returns in 2025, but that those gains should run roughly equal to the level of earnings growth, leaving the market set up for low double-digit gains in 2025. He says that technology continues to provide a tailwind to the market, though henotes that the artificial intelligence evolution makes for a moving target where investors might want to gravitate towards industries that are adjacent to AI, making money off of the companies and sectors that use AI to drive profit gains. Ladner — whose firm practices goals-based planning — noted that while the U.S. economy remains the world's strongest, it would be a mistake to ignore international markets now. Leigh Purvis, prescription drug policy principal at the AARP Public Policy Institute discusses her research into showing that prices on brand-name drugs have been rising much faster than the rate of general inflation for decades, creating challenges — particularly for Medicare Part D enrollees — that many people have addressed by not refilling prescriptions or by skipping doses to make prescriptions last longer. Plus Dan Crowley, partner at Nightview Capital — portfolio manager of the Nightview Fund — brings his concentrated growth approach to the Market Call.

Today, we are honored to have Leigh Purvis with AARP joining us today. She is the principal on prescription drug policy at AARP's Public Policy Institute, and she is instrumental in leading efforts to improve prescription drug affordability and accessibility for older adults. In this episode, we get into some critical updates and changes to Medicare with Leigh, hitting on key topics such as open enrollment dates, the introduction of new out-of-pocket spending caps, new monthly caps on insulin copays, and new vaccine benefits. Leigh also sheds light on the importance of reviewing and understanding plan options to ensure better healthcare coverage and costs for Medicare beneficiaries. Get ready for an episode packed with valuable insights and practical advice that you won't want to miss!Website: AARP Medicare ResourcesSeniorLivingGuide.com Podcast sponsored by TransMed Care Long Distance Medical Transportation The background music is written, performed and produced exclusively by purple-planet.com.https://www.purple-planet.com/ *SeniorLivingGuide.com Webinars and Podcast represents the opinions and expertise of our guests. The content here is for informational and educational purposes. It does not necessarily represent the views, recommendations, opinions or advice of Fairfax Publishing/SeniorLivingGuide.com or its employees  

00:00 Show open/ Sickle Cell research and clinical trial information with Dr. Courtney Fitzhugh from the National Institutes of Health. 8:01 Changes to Medicare with Leigh Purvis, Prescription Drug Policy Principal for the American Association of Retired Persons. 13:00 Dr Carolyn Hendricks on Staq Pharma manufacturing a cancer drug that is currently in short supply with Nationwide Children's Hospital at their Columbus facility. 18:05 Face the State: A look back at the Vice-Presidential debate and other election topics with Republican strategist Terry Casey and Democratic strategist Dale Butland. 31:21 Face the State: Important dates and reminders for voting in Ohio's upcoming general election with Aaron Sellers of the Franklin County Board of Elections. Warning about a text scam that claims people are not registered to vote.

January 19, 2023 - Leigh Purvis

January 19, 2023 - Leigh Purvis

AARP's Leigh Purvis discusses how significant the Inflation Reduction Act is for older Americans, especially in Medicare Part D.  What is addressed is out of control prescription drug prices and certain caps that may help eligible citizens. AARP publishes a prescription price watch and also has a Medicare Q and A section on its website, which is further discussed. Details are given on when people should apply for Medicare without penalty. Being Well Informed airs weekly on various podcast platforms, including Podbean, Apple Podcasts, Google Podcasts, You Tube, iHeart Radio, and Spotify. 

Welcome back to In Clear Terms with AARP California! This week, host Dr. Thyonne Gordon speaks with AARP Director of Healthcare Costs and Access, Leigh Purvis! Leigh speaks about the various reasons that prescription drug prices are so high in America, which means some older adults are forced to choose between life-saving medication and other expenses like rent or food. Learn how AARP is fighting for a cap on out-of-pocket costs and working to ensure that older adults and people of all ages are not taken advantage of by drug companies. Hit play and enjoy this fascinating episode of In Clear Terms with AARP California. We are here to empower you with the facts and information that will help make California more livable for people of all ages.Follow UsTwitter @AARPCAFacebook @aarpcaliforniaInstagram @aarpcaPresented by AARP Californiahttps://states.aarp.org/california/

00:00 Show Open / Brandon Smith, Producer of ‘Tecumseh!' – The Outdoor Drama in Chillicothe, which begins its 50th anniversary season this week. 17:00 Courtesy of our sister station, WBNS 10-TV, Brittany Bailey looks at issues that include gun legislation and a bill that would restrict discussion in school classrooms dealing with gender identification and sexual orientation. 44:00 Dara Lieberman, Director of Government Relations at Trust For America's Health, discuses public health preparedness. 51:30 Leigh Purvis, Director of Health Care Costs and Access for AARP, discusses the high cost of ‘specialty' prescription drugs.

00:00 Show Open / John Pappas, State Advocacy Director for iDEA Growth, which represents sectors involved in online gaming and sports betting - an industry that could soon be legalized in Ohio. 26:00 Scott DiMauro, President of the Ohio Education Association, discusses how public educators in Ohio are navigating their way through the pandemic. 51:00 Leigh Purvis, Director of Health Care Costs and Access for AARP, discusses the high cost of 'specialty' prescription drugs.

A new survey finds that most older Americans struggle to keep up with prescription costs. In fact, our guests say that people often have to make a choice between food and medicine. Today, we discuss the impossible situation of high prescription costs with Larry Zarzecki, a retired police officer who lives with Parkinson's disease -- and his treatment costs over $3,000 per month. And, we'll hear about potential ways to lower prescription prices with AARP's Leigh Purvis.

Prescription drug prices are skyrocketing, much faster than the rate of inflation. What's causing this? How can you help? We'll get some answers from Leigh Purvis of AARP. Did you know that Australia has recently pieced together parts of what makes up the largest dinosaur thought to roam the land there? Dr. Scott Hocknull of the Queensland Museum in Brisbane joins us to tell us all about it. See omnystudio.com/listener for privacy information.

Back in September, AARP, issued its latest Rx Price Watch report, which highlighted the problem of skyrocketing drug costs; it found the retail prices for widely used drugs increased well above the rate of inflation, and that’s a troubling trend for Medicare beneficiaries. This week on the podcast, we’re speaking with one of the authors of that report, Leigh Purvis, MPA, who says that the problem of high costs will eventually impact all Americans. 

We’re joined by Leigh Purvis of AARP to discuss why prescription drug prices are so high in the U.S., possible policy solutions, and what you can do in the meantime to save money.

At a hearing this week, Senators from both parties grilled executives from major pharmaceutical companies about skyrocketing drug prices. AARP’s Leigh Purvis shares how this impacts us all and why Congress needs to act now.

With the election right around the corner, Bob Edwards dives into the key issue that, regardless of party affiliation, voters want Washington to address and AARP’s Leigh Purvis breaks down a recent report on the surging cost of prescription drugs.

This week on the podcast, we’re pleased to welcome our guest, Leigh Purvis, MPA. Purvis is the director of health services research at AARP’s public policy institute. Her work focuses on a variety of prescription drug and mental health-related issue, with an emphasis on prescription drug pricing, biologic drugs, and prescription drug coverage under Medicare.  Purvis joined us by phone to talk about the challenges that Medicare beneficiaries face with respect to obtaining and paying for their biologic drugs, and about the policies that AARP hopes to see implemented in the days ahead.

December 15, 2016 - A Son of a Pitch Christopher Wedge, AARP Leigh Purvis & 5/3 Bank Melissa Register

Retail prices for more than 100 widely used specialty drugs rose nearly 11 percent in 2013, according to a new report from AARP Public Policy Institute. The report found that the average annual cost of a specialty drugs used to treat chronic diseases rose to more than $53,000 — greater than the U.S. median income and more than twice the $23,500 median income of people on Medicare. We spoke to Leigh Purvis, director of health services research in AARP's Public Policy Institute about the report, trends that are fueling demand for these drugs, and whether there are public policy solutions to rein in rising drug prices that can be implemented without harm to innovation.